Quantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectional Study

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

December 15, 2023

Conditions
Pleural EffusionMalignant Pleural EffusionsTuberculous Pleural Effusion
Interventions
DIAGNOSTIC_TEST

Pleural Fluid Quantitative C-Reactive Protein (Q-CRP) Measurement

The intervention involves the measurement of Quantitative C-Reactive Protein (Q-CRP) levels in pleural fluid obtained from patients presenting with lymphocytic exudative pleural effusion. The Q-CRP test is performed using standardized laboratory methods to quantitatively analyze CRP levels, which are then compared between patients with confirmed tuberculous pleural effusion and those with malignant pleural effusion. This diagnostic approach aims to evaluate the efficacy of pleural fluid Q-CRP as a biomarker to differentiate between these two conditions. No therapeutic or invasive interventions are introduced as part of this study beyond routine diagnostic procedures.

Trial Locations (1)

44600

Institute of Medicine, Maharajgunj, Kathmandu

All Listed Sponsors
lead

Maharajgunj Medical Campus

OTHER